Skip to main content
TipRanks
Go Ultimate75% OFF

Haleon PLC Sponsored ADR (HLN) Revenue by Segment

325 Followers

Revenue by Segment

In Q2 2026, Haleon PLC Sponsored ADR reported revenue by segment of £906.00M (Oral Health), £435.00M (VMS), £669.00M (Pain Relief), £351.00M (Respiratory Health) and £251.00M (Digestive Health & Other).

Shows how revenue is distributed across different business units, highlighting which areas are driving growth and which may need strategic adjustments.

£0.00£500.00M£1.00B£1.50B£2.00B£2.50B£3.00BMar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Haleon PLC's Oral Health segment shows consistent growth, peaking in early 2024, indicating strong consumer demand. VMS remains stable with slight fluctuations, suggesting steady market presence. Pain Relief and Respiratory Health exhibit seasonal patterns, with notable peaks in the first quarter, potentially driven by increased consumer needs during colder months. Digestive Health & Other faces a declining trend in late 2024, which could signal shifting consumer preferences or competitive pressures. Without earnings call insights, these trends highlight the importance of strategic focus on Oral Health and addressing challenges in Digestive Health.

HLN Revenue by Segment

PeriodOral HealthVMSPain ReliefRespiratory HealthDigestive Health & Other
Q2 2026Jun 30, 2026£906.00M£435.00M£669.00M£351.00M£251.00M
Q1 2026Mar 31, 2026£932.00M£414.00M£654.00M£499.00M£239.00M
Q4 2025Dec 31, 2025£866.00M£430.00M£631.00M£470.00M£256.00M
Q3 2025Sep 30, 2025£867.00M£422.00M£647.00M£510.00M£240.00M
Q2 2025Jun 30, 2025£848.00M£417.00M£625.00M£368.00M£237.00M
Q1 2025Mar 31, 2025£880.00M£416.00M£661.00M£525.00M£254.00M
Q4 2024Dec 31, 2024£819.00M£432.00M£633.00M£433.00M£442.00M
Q3 2024Sep 30, 2024£810.00M£407.00M£628.00M£456.00M£479.00M
Q2 2024Jun 30, 2024£829.00M£435.00M£641.00M£318.00M£552.00M
Q1 2024Mar 31, 2024£854.00M£422.00M£662.00M£470.00M£511.00M
Q4 2023Dec 31, 2023£757.00M£414.00M£611.00M£458.00M£526.00M
Q3 2023Sep 30, 2023£790.00M£410.00M£636.00M£439.00M£523.00M
Q2 2023Jun 30, 2023£778.00M£411.00M£681.00M£329.00M£553.00M
Q1 2023Mar 31, 2023£811.00M£405.00M£724.00M£510.00M£536.00M
Q4 2022Dec 31, 2022£732.00M£422.00M£655.00M£439.00M£530.00M
Q3 2022Sep 30, 2022£787.00M£437.00M£648.00M£457.00M£563.00M
Q2 2022Jun 30, 2022£697.00M£411.00M£613.00M£316.00M£524.00M
Q1 2022Mar 31, 2022£741.00M£405.00M£635.00M£367.00M£479.00M

Related KPIs